Literature DB >> 11355802

Recurrent pregnancy loss: summary and clinical recommendations.

R M Lee1, R M Silver.   

Abstract

Recurrent pregnancy loss (RPL) is traditionally defined as three or more consecutive pregnancy losses before 20 weeks of gestation. This problem occurs in approximately 1% of all couples and is a frustrating problem for both the patient and physician. This article provides an overview of the problem, including causes, treatments, and recommendations. Among the numerous proposed causes of RPL, only parental karyotype abnormalities, antiphospholipid syndrome, uterine malformations, and cervical incompetence are universally accepted. There are numerous treatments for RPL, but only the efficacy of heparin and low-dose aspirin in women with antiphospholipid syndrome has been established with properly controlled trials. Even after undertaking a complete evaluation, the cause of RPL remains uncertain in over 50% of cases. These patients should understand that subsequent pregnancies have up to a 70% chance of success without treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11355802     DOI: 10.1055/s-2000-13733

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  23 in total

1.  Decreased mean platelet volume is associated with the developing stage of fetoplacental unit in spontaneous abortion.

Authors:  Mustafa Kaplanoglu; Tuncay Yuce; Mehmet Bulbul
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Migraine during pregnancy: options for therapy.

Authors:  Anthony W Fox; Merle L Diamond; Egilius L H Spierings
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction.

Authors:  Elnaz Mosaferi; Jafar Majidi; Mojdeh Mohammadian; Zohreh Babaloo; Amir Monfaredan; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2013-08-20

4.  Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors:  Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal:  Thyroid       Date:  2011-07-25       Impact factor: 6.568

5.  The influence of socio-demographic factors on miscarriage incidence among Italian and immigrant women: a critical analysis from Italy.

Authors:  Donatella Caserta; Eleonora Ralli; Eleonora Matteucci; Giulia Bordi; Ilaria Soave; Roberto Marci; Flaviano Moscarini
Journal:  J Immigr Minor Health       Date:  2015-06

6.  Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population.

Authors:  G Ventolini; M Zhang; J Gruber
Journal:  Surg Endosc       Date:  2004-10-26       Impact factor: 4.584

7.  Cytogenetic analysis in couples with recurrent miscarriages: a retrospective study from Punjab, north India.

Authors:  Neha Sudhir; Tajinder Kaur; Archana Beri; Anupam Kaur
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

8.  Preconception low dose aspirin and time to pregnancy: findings from the effects of aspirin in gestation and reproduction randomized trial.

Authors:  Enrique F Schisterman; Sunni L Mumford; Karen C Schliep; Lindsey A Sjaarda; Joseph B Stanford; Laurie L Lesher; Jean Wactawski-Wende; Anne M Lynch; Janet M Townsend; Neil J Perkins; Shvetha M Zarek; Michael Y Tsai; Zhen Chen; David Faraggi; Noya Galai; Robert M Silver
Journal:  J Clin Endocrinol Metab       Date:  2015-02-24       Impact factor: 5.958

9.  Evaluation of transvaginal peritoneal surgery in young female patients.

Authors:  Masaaki Tanaka; Tetsuya Sagawa; Rena Yamazaki; Subaru Myojo; Satoshi Dohi; Masaki Inoue
Journal:  Surg Endosc       Date:  2013-02-07       Impact factor: 4.584

Review 10.  Antiphospholipid antibodies in pediatrics.

Authors:  Ana I Quintero-Del-Rio
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.